Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Gareth P Gregory

A consensus statement on the use of biosimilar medicines in hematology in Australia

scientific article published on 14 April 2020

A novel CDK9 inhibitor increases the efficacy of venetoclax (ABT-199) in multiple models of hematologic malignancies

scientific article published on 11 December 2019

AZD4320, a dual inhibitor of Bcl-2 and Bcl-xL, induces tumor regression in hematological cancer models without dose-limiting thrombocytopenia

scientific article published on 28 September 2020

BET Inhibition Induces Apoptosis in Aggressive B-Cell Lymphoma via Epigenetic Regulation of BCL-2 Family Members

scientific article published on 12 July 2016

Bcor loss perturbs myeloid differentiation and promotes leukaemogenesis

scientific article published on 22 March 2019

CDK13 cooperates with CDK12 to control global RNA polymerase II processivity

scientific article published on 29 April 2020

CDK9 inhibition by dinaciclib potently suppresses Mcl-1 to induce durable apoptotic responses in aggressive MYC-driven B-cell lymphoma in vivo.

scientific article published on 12 January 2014

Cold agglutinin disease complicated by acrocyanosis and necrosis

scientific article published on 3 January 2017

Correct diagnosis of NK and T cell lymphomas

scientific article published on June 1, 2012

Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia

scientific article published in Nature Communications

Disseminated histoplasmosis complicating HIV infection

scientific article published on 01 December 2012

Excellent outcomes in older patients with primary CNS lymphoma treated with R-MPV/cytarabine without whole brain radiotherapy or autologous stem cell transplantation therapy

scientific article published on 27 September 2020

Failure of eculizumab to correct paroxysmal cold hemoglobinuria

scientific article published on 26 November 2010

Failure of tofacitinib to achieve an objective response in a DDX3X-MLLT10 T-lymphoblastic leukemia with activating JAK3 mutations

scientific article published on 25 August 2020

Failure to achieve early disease response is associated with inferior survival in patients with newly diagnosed multiple myeloma.

scientific article

Genomic characterisation of Eμ-Myc mouse lymphomas identifies Bcor as a Myc co-operative tumour-suppressor gene

scientific article published on 06 March 2017

Infusional dose-adjusted epoch plus bortezomib for the treatment of plasmablastic lymphoma

scientific article published on 23 January 2016

Passenger lymphocyte syndrome after lung transplant

scientific article published on 15 November 2012

Prevention and management of obinutuzumab-associated toxicities: Australian experience

scientific article published on 01 December 2015

Rational combination therapies targeting survival signaling in aggressive B-cell leukemia/lymphoma

scientific article published on July 2014

Rituximab is associated with improved survival for aggressive B cell CNS lymphoma

scientific article published on March 15, 2013

Serine Biosynthesis Is a Metabolic Vulnerability in FLT3-ITD–Driven Acute Myeloid Leukemia

scientific article published on 12 January 2021

The CDK9 Inhibitor Dinaciclib Exerts Potent Apoptotic and Antitumor Effects in Preclinical Models of MLL-Rearranged Acute Myeloid Leukemia.

scientific article published in December 2015